Literature DB >> 7824104

Cerebrospinal fluid of Parkinson's disease patients inhibits the growth and function of dopaminergic neurons in culture.

R Hao1, R B Norgren, Y S Lau, R F Pfeiffer.   

Abstract

We report the possible existence of an inhibitory factor in the CSF of Parkinson's disease patients that inhibits the function and growth of dopaminergic neurons in rat mesencephalic culture. After 40 hours' exposure to the < 10 kd fraction of CSF from PD patients, the high-affinity dopamine uptake was 66% of that of cultures exposed to CSF from controls. However, the number of dopaminergic neurons remained unchanged at this time. After 90 hours' exposure to the < 10 kd fraction of CSF from PD patients, the number of dopaminergic neurons decreased to 10% of that in cultures exposed to CSF from controls, and the size of the remaining dopaminergic neurons in the culture became smaller. This inhibitory factor did not affect the growth of other types of neurons. The chemical nature of this inhibitory factor is under investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824104     DOI: 10.1212/wnl.45.1.138

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Treatment of spinal cord injury by transplantation of cells via cerebrospinal fluid.

Authors:  Yan Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2008-10       Impact factor: 5.203

2.  Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.

Authors:  Y S Lau; R Hao; Y K Fung; L S Fu; J F Bishop; R F Pfeiffer; M M Mouradian
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

3.  Experimental study of serum substantia nigra neuron autoantibody and its effect in Parkinson disease patients.

Authors:  J Chen; X Cao; Y Xu; S Sun
Journal:  J Tongji Med Univ       Date:  2001

4.  1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.

Authors:  Agnieszka Wasik; Irena Romańska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-02-10       Impact factor: 3.911

5.  CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes.

Authors:  Mya C Schiess; Jennifer L Barnes; Timothy M Ellmore; Brian J Poindexter; Kha Dinh; Roger J Bick
Journal:  BMC Neurosci       Date:  2010-11-29       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.